Pharmacokinetics of clobazam oral soluble film

20186 citationsJournal Articlehybrid Open Access

Authors

Allen H. Heller · Bridge Pharma (United States)

Stephen Wargacki · Aquestive (United States)

Cassie Jung · Aquestive (United States)

Carla Buan · Aquestive (United States)

D.J. Wyatt · Syneos Health (United States)

A. Mark Schobel · Aquestive (United States)

Abstract

COSF is a novel clobazam dosage form that is bioequivalent to CTAB. Because of its ease of administration, COSF may be expected to improve adherence, reduce likelihood of dosing error, and provide more accurate dosing than formulations of clobazam that are currently available.

Topics & Keywords

Epilepsy research and treatment Pharmacological Effects and Toxicity Studies Antibiotics Pharmacokinetics and Efficacy

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Epilepsia

Volume 59, Issue 11, pp. 2153-2161

DOI: 10.1111/epi.14581

Field-Weighted Citation Impact: 0.32